Overview
Join us for the third annual BIOMEDevice Executive Forum as we focus on convergence and cross-sector collaborations among biotechnology, medical device, IVD, and pharmaceutical companies.
This two-day conference will provide you with the resources you need to strengthen connections between key stakeholders involved in investing, partnering, licensing, and developing business opportunities in the rapidly growing market for innovative healthcare products. This year's forum will feature a new company presentation track produced exclusively by BayBio.
The forum's scope moves beyond the FDA's definition of a combination product to address the paradigm shift in the life sciences. Join us to hear what's driving convergence within and across the life science sectors and examine strategies to harness the potential of innovation.
Invest two days at the forum and walk away empowered with critical information to navigate the complex landscape of convergent medical technologies and maintain a competitive advantage.
Hear where convergence is headed from leaders in the life science industry
Identify and analyze key areas for growth and strategies to assess risk
Discuss how medtech entrepreneurs can distinguish themselves in a crowded market
Identify and examine new models for cross-sector collaborations
Analyze innovation in the areas of drug delivery and diagnostics
Study the unique challenges and opportunities posed by convergence—focusing on strategies to address the regulatory, reimbursement, and intellectual property issues
Featuring New Company Presentation Track
Join BayBio at the third annual BIOMEDevice Executive Forum. The Company Presentations Track was produced exclusively by BayBio and will run concurrently with the BIOMEDevice Executive Forum. The company presentations will feature 20-minute presentations by the hottest medical device and diagnostic companies from early stage to series C.
Carefully selected by the BIOMEDevice Company Presentations Advisory Board, presenting executives will have the opportunity to introduce the company, highlight key technologies, alliances, and where they stand with product & clinical developments.
Submit Application to Present
Presenting Companies will be provided with an opportunity to showcase their company story in presentations to qualified investors, as well as one-on-one meetings with new and current investors, analysts, and partnering companies.
To participate as a presenting company, please submit proposal form to BIOMEDevice Advisory Committee. While there is no presentation fee, company executives must register to attend the conference. All proposals are due on or before 5:00pm PST on November 13, 2009
Request Investor Registration
Public and private equity investors, research analysts and investment bankers focused on investment in the life sciences sector will be provided with an opportunity to learn of the research and development at the top life sciences growth companies in Northern California.
To receive a complimentary conference registration - please send your request to BayBio. Only qualified investors will receive complimentary registration. All requests must be received on or before 5:00pm PST on December 4, 2009 |
Who Should Attend
Senior-level executives at biotechnology, medical device, and pharmaceutical companies with responsibility for corporate management or business development; R&D executives from mature and emerging life sciences firms; investors in medical technology ventures, including angel investors, venture capitalists, and investment bankers; and industry analysts.
About the Sponsors and Producers
R&D Directions provides insight into pharmaceutical research and development, from discovery through clinical trials and submission. Leaving the hard science to other publications, R&D Directions focuses on pharmaceutical companies' R&D business strategies and decisions. Editorial content covers drugs, therapeutic categories, industry segments, and strategies, and imparts extensive intelligence on products in the pipeline. Although R&D Directions contains a wealth of medical and scientific information, it is written in a non-clinical, non-technical style.
IVD Technology
IVD Technology (IVDT) is the only trade journal designed exclusively for manufacturers of in vitro diagnostic products. Written by leading experts in their fields, IVDT's peer-reviewed articles cover a wide range of technical and regulatory topics. The publication’s primary focus is on diagnostics technologies—including research, development, and manufacturing. IVDT articles contain authoritative information on all aspects of manufacturing immunoassays, nucleic-acid-based diagnostics, clinical chemistry tests, and related instrumentation.
BayBio
BayBio is an independent, non-profit trade association serving the life science industry in Northern California, through offices and representatives in South San Francisco, Berkeley and Sacramento, and through coalition partners in Washington, DC. The association supports the regional bioscience community through advocacy, enterprise support, and the enhancement of research collaboration. Its more than 450 member companies include organizations engaged in, or supportive of, research, development and commercialization of life science technologies. |
